Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The therapeutic nuclear medicine market is foreseen to register a CAGR of 4.10% from 2024 to 2034, with a market valuation of US$ 1.32 billion in 2024. Developing demand is invoked to set a valuation of US$ 1.97 billion in 2034 for the market.
Attributes | Details |
---|---|
Market Value for 2024 | US$ 1.32 billion |
Market Value for 2034 | US$ 1.97 billion |
Market Forecast CAGR for 2024 to 2034 | 4.10% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The historical CAGR of 11.70% was recorded for the market and a 4.10% CAGR is calculated through 2034. The market is evolving with the introduction of the product in palliative therapy, taking advantage of the lack of response to different treatments for distressing bone metastasis.
Attributes | Details |
---|---|
Historical CAGR for 2019 to 2023 | 11.70% |
Acute aspects that are anticipated to influence the demand for the product through 2034 include:
Cancer and Cardiovascular Diseases See Stakes Rise in the Demand for the Market
The Geriatric Population Demands Innovation in the Industry
Establishments Perform Novel Research and Development in Therapeutic Nuclear Medicine
The following section compares the therapeutic nuclear medicine market to the pet cancer therapeutics market and exosome diagnostic and therapeutic market, examining trends, opportunities, and CAGR from 2024 to 2034.
Therapeutic Nuclear Medicine Market:
Attributes | Therapeutic Nuclear Medicine Market |
---|---|
CAGR (2024 to 2034) | 4.1% |
Opportunity | Growing prevalence of cancer presents growth prospects in therapeutic nuclear medication |
Key Trends | Rise in research and development in cancer treatment |
Exosomes Diagnostic and Therapeutic Market:
Attributes | Exosomes Diagnostic and Therapeutic Market |
---|---|
CAGR (2024 to 2034) | 9.1% |
Opportunity | Manufactures developing generic drug alternatives |
Key Trends | Novel clinical applications of exosome biomarkers |
Pet Cancer Therapeutics Market:
Attributes | Pet Cancer Therapeutics Market |
---|---|
CAGR (2024 to 2034) | 10.0% |
Opportunity | Market players developing cancer screenings and treatments for pets |
Key Trends | Improvements in veterinary medicine |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The following part offers an in-depth segmental analysis of the therapeutic nuclear medicine market. The demand for Radium-223 is significant, whereas the demand for prostate cancer treatment is anticipated to be augmented in 2024.
Attributes | Details |
---|---|
Top Radionuclide Type | Radium-223 |
Market share in 2024 | 77.50% |
The demand for Radium-223 is significant, slotted in to acquire a market share of 77.5% in 2024. The following aspects aid the development of demand for Radium-223:
Attributes | Details |
---|---|
Top Indication | Prostate Cancer |
Market share in 2024 | 55.60% |
Prostate cancer is penned in to acquire a market share by indication of 55.6% in 2024. The following aspects aid the development of the medicines in prostate cancer treatment:
According to derived data, the demand from European countries is supposed to augment the sales growth of the medicines in the forthcoming decade. The industry in France and Germany is developing steeply. The therapeutic nuclear medication industry in the United Kingdom is anticipated to register a subordinate CAGR compared to other European nations. The demand for treatment is developing rapidly in Italy and Russia.
Countries | CAGR from 2024 to 2034 |
---|---|
Russia | 6.4% |
Germany | 4.4% |
Italy | 5.4% |
United Kingdom | 3.5% |
France | 5.0% |
Through 2034, the therapeutic nuclear medicine industry in Russia is anticipated to register a 6.4% CAGR, owing to the development of prominent and emerging pharmaceutical and neurological research organizations.
In Russia, nuclear medicine is used to diagnose and treat various diseases, particularly cardiovascular and neurological conditions, but the key focus has always been placed on oncology.
The demand for these medicines is projected to report a CAGR of 4.4% in Germany by 2034 due to the prevalence of chronic diseases such as neuroendocrine tumors, prostate cancer, meningiomas, thyroid cancer, and lymphoma.
As therapeutic nuclear drugs are considered effective drugs for the treatment of cancer in the initial stages, thus German research and development organizations are developing novel radiopharmaceutical therapies.
Although therapeutic nuclear treatments’ future seems promising in the country, the German health regulatory bodies plummet the growth rate of radiopharmaceutical therapies.
The demand for these medicines in Italy is anticipated to showcase a CAGR of 5.4% between 2024 and 2034 as geriatric patients grow nationwide. The Italian medical environment targets the research and development of effective nuclear treatments that can aid in senior health.
The demand for these medicines in France is projected to report a CAGR of 5.0% from 2024 to 2034, as the French field of nuclear medicine and theranostics is developing rapidly. France has over two hundred nuclear medicine departments that use radionuclides for diagnostic or therapeutic objectives in various domains such as oncology, cardiology, neurology, or endocrinology. The medical community is promoting therapeutic nuclear treatment in healthcare environments.
Sales of therapeutic nuclear medicines in the United Kingdom are set to witness a CAGR of 3.5% through 2034. Therapeutic nuclear medicine in the United Kingdom has developed fairly inconsistently over the last half-century.
Nonetheless, the regular climate shifts in the United Kingdom have created a prevalence of cardiovascular illnesses, necessitating the use of therapeutic nuclear medication. The rising geriatric population in the United Kingdom demands innovation in radioisotope therapies aiding in the treatment of prostate cancer.
The therapeutic nuclear medicine industry’s dynamics are changing, and the key market players are vying for the majority stake in the competitive environment. Market players are implementing organic marketing techniques such as mergers and acquisitions, collaborations, and product launches to acquire a competitive advantage.
Top players produce the majority of nuclear medicine treatment products. Industry leaders have built their position in the market by investing more in research and having a better distribution system.
Recent technological developments in nuclear imaging modalities and the introduction of innovative pharmaceuticals into the global market have given the industry a huge boost. Continued and persistent research and development activities that result in betterment in new application areas are pushing market expansion.
Recent Developments in the Therapeutic Nuclear Medicine Market
The market is set to be valued at US$ 1.32 billion in 2024.
The therapeutic nuclear medicine industry is anticipated to be valued at US$ 1.97 billion by 2034.
In the United Kingdom, demand is anticipated to develop at a CAGR of 3.5% by 2034.
The therapeutic nuclear medicine industry is projected to register a CAGR of 4.10% from 2024 to 2034.
Therapeutic nuclear medicine industry has the following segments: treatment, indication, and distribution channel.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants 3.5.1.3. Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Distributors 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Treatment, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Treatment, 2024 to 2034 5.3.1. Radium-223 5.3.2. Iodine-131 5.3.3. Leutitium-177 5.3.4. Yttrium-90 5.3.5. Samarium-153 5.3.6. Strontium-89 5.3.7. Rhenium-188+Rhenium-186 5.3.8. Erbium- 169 5.3.9. Phosphorous-32 5.3.10. Others 5.4. Y-o-Y Growth Trend Analysis By Treatment, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Treatment, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Indication, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Indication, 2024 to 2034 6.3.1. Prostate Cancer 6.3.2. Painful Bone Metastases 6.3.3. Thyroid Cancer 6.3.4. Neuroblastoma 6.3.5. Synovitis 6.3.6. Non-Hodgkin’s Lymphoma 6.3.7. Hepatic Metastases 6.3.8. Brain Tumour 6.3.9. Others 6.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Distribution Channel, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Distribution Channel, 2024 to 2034 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centres 7.3.3. Cancer Research Institutes 7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Treatment 9.2.3. By Indication 9.2.4. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Treatment 9.3.3. By Indication 9.3.4. By Distribution Channel 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Treatment 10.2.3. By Indication 10.2.4. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Treatment 10.3.3. By Indication 10.3.4. By Distribution Channel 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Treatment 11.2.3. By Indication 11.2.4. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Treatment 11.3.3. By Indication 11.3.4. By Distribution Channel 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Treatment 12.2.3. By Indication 12.2.4. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Treatment 12.3.3. By Indication 12.3.4. By Distribution Channel 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Treatment 13.2.3. By Indication 13.2.4. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Treatment 13.3.3. By Indication 13.3.4. By Distribution Channel 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Treatment 14.2.3. By Indication 14.2.4. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Treatment 14.3.3. By Indication 14.3.4. By Distribution Channel 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Treatment 15.2.3. By Indication 15.2.4. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Treatment 15.3.3. By Indication 15.3.4. By Distribution Channel 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Treatment 16.1.2.2. By Indication 16.1.2.3. By Distribution Channel 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Treatment 16.2.2.2. By Indication 16.2.2.3. By Distribution Channel 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Treatment 16.3.2.2. By Indication 16.3.2.3. By Distribution Channel 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Treatment 16.4.2.2. By Indication 16.4.2.3. By Distribution Channel 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Treatment 16.5.2.2. By Indication 16.5.2.3. By Distribution Channel 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Treatment 16.6.2.2. By Indication 16.6.2.3. By Distribution Channel 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Treatment 16.7.2.2. By Indication 16.7.2.3. By Distribution Channel 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Treatment 16.8.2.2. By Indication 16.8.2.3. By Distribution Channel 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Treatment 16.9.2.2. By Indication 16.9.2.3. By Distribution Channel 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Treatment 16.10.2.2. By Indication 16.10.2.3. By Distribution Channel 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Treatment 16.11.2.2. By Indication 16.11.2.3. By Distribution Channel 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Treatment 16.12.2.2. By Indication 16.12.2.3. By Distribution Channel 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Treatment 16.13.2.2. By Indication 16.13.2.3. By Distribution Channel 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Treatment 16.14.2.2. By Indication 16.14.2.3. By Distribution Channel 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Treatment 16.15.2.2. By Indication 16.15.2.3. By Distribution Channel 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Treatment 16.16.2.2. By Indication 16.16.2.3. By Distribution Channel 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Treatment 16.17.2.2. By Indication 16.17.2.3. By Distribution Channel 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Treatment 16.18.2.2. By Indication 16.18.2.3. By Distribution Channel 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Treatment 16.19.2.2. By Indication 16.19.2.3. By Distribution Channel 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Treatment 16.20.2.2. By Indication 16.20.2.3. By Distribution Channel 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Treatment 16.21.2.2. By Indication 16.21.2.3. By Distribution Channel 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Treatment 16.22.2.2. By Indication 16.22.2.3. By Distribution Channel 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Treatment 16.23.2.2. By Indication 16.23.2.3. By Distribution Channel 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Treatment 17.3.3. By Indication 17.3.4. By Distribution Channel 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Bayer AG 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. GE Healthcare 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Novartis AG 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Cardinal Health Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Mallinckrodt plc. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Lantheus Medical Imaging Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Bracco Imaging S.p.A 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Eckert & Ziegler 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Curium Pharma 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. International Isotopes Idaho, Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Medi-Radiopharma Co., Ltd. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034 Table 2: Global Market Volume (Unit Pack) Forecast by Region, 2019 to 2034 Table 3: Global Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 4: Global Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 5: Global Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 6: Global Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 7: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 8: Global Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 9: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 10: North America Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 11: North America Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 12: North America Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 13: North America Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 14: North America Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 15: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 16: North America Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 17: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 18: Latin America Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 19: Latin America Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 20: Latin America Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 21: Latin America Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 22: Latin America Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 23: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 24: Latin America Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 25: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 26: Western Europe Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 27: Western Europe Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 28: Western Europe Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 29: Western Europe Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 30: Western Europe Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 31: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 32: Western Europe Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 33: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 34: Eastern Europe Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 35: Eastern Europe Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 36: Eastern Europe Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 37: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 38: Eastern Europe Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 39: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 40: Eastern Europe Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 42: South Asia and Pacific Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 43: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 44: South Asia and Pacific Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 45: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 46: South Asia and Pacific Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 47: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 48: South Asia and Pacific Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 49: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 50: East Asia Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 51: East Asia Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 52: East Asia Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 53: East Asia Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 54: East Asia Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 55: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 56: East Asia Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034 Table 57: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034 Table 58: Middle East and Africa Market Volume (Unit Pack) Forecast by Country, 2019 to 2034 Table 59: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2019 to 2034 Table 60: Middle East and Africa Market Volume (Unit Pack) Forecast by Treatment, 2019 to 2034 Table 61: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2019 to 2034 Table 62: Middle East and Africa Market Volume (Unit Pack) Forecast by Indication, 2019 to 2034 Table 63: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034 Table 64: Middle East and Africa Market Volume (Unit Pack) Forecast by Distribution Channel, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 2: Global Market Value (US$ Million) by Indication, 2024 to 2034 Figure 3: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034 Figure 6: Global Market Volume (Unit Pack) Analysis by Region, 2019 to 2034 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034 Figure 9: Global Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 10: Global Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 11: Global Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 12: Global Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 13: Global Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 14: Global Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 15: Global Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 16: Global Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 17: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 18: Global Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 21: Global Market Attractiveness by Treatment, 2024 to 2034 Figure 22: Global Market Attractiveness by Indication, 2024 to 2034 Figure 23: Global Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 24: Global Market Attractiveness by Region, 2024 to 2034 Figure 25: North America Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 26: North America Market Value (US$ Million) by Indication, 2024 to 2034 Figure 27: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 28: North America Market Value (US$ Million) by Country, 2024 to 2034 Figure 29: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 30: North America Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 33: North America Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 34: North America Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 35: North America Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 36: North America Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 37: North America Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 38: North America Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 39: North America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 40: North America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 41: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 42: North America Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 43: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 44: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 45: North America Market Attractiveness by Treatment, 2024 to 2034 Figure 46: North America Market Attractiveness by Indication, 2024 to 2034 Figure 47: North America Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 48: North America Market Attractiveness by Country, 2024 to 2034 Figure 49: Latin America Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 50: Latin America Market Value (US$ Million) by Indication, 2024 to 2034 Figure 51: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 52: Latin America Market Value (US$ Million) by Country, 2024 to 2034 Figure 53: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 54: Latin America Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 57: Latin America Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 58: Latin America Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 59: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 61: Latin America Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 62: Latin America Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 65: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 66: Latin America Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 67: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 68: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 69: Latin America Market Attractiveness by Treatment, 2024 to 2034 Figure 70: Latin America Market Attractiveness by Indication, 2024 to 2034 Figure 71: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034 Figure 73: Western Europe Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 74: Western Europe Market Value (US$ Million) by Indication, 2024 to 2034 Figure 75: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 76: Western Europe Market Value (US$ Million) by Country, 2024 to 2034 Figure 77: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 78: Western Europe Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 81: Western Europe Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 82: Western Europe Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 85: Western Europe Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 86: Western Europe Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 89: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 90: Western Europe Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 93: Western Europe Market Attractiveness by Treatment, 2024 to 2034 Figure 94: Western Europe Market Attractiveness by Indication, 2024 to 2034 Figure 95: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034 Figure 97: Eastern Europe Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 98: Eastern Europe Market Value (US$ Million) by Indication, 2024 to 2034 Figure 99: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 100: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034 Figure 101: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 102: Eastern Europe Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 105: Eastern Europe Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 106: Eastern Europe Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 109: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 110: Eastern Europe Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 113: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 114: Eastern Europe Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 117: Eastern Europe Market Attractiveness by Treatment, 2024 to 2034 Figure 118: Eastern Europe Market Attractiveness by Indication, 2024 to 2034 Figure 119: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034 Figure 121: South Asia and Pacific Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 122: South Asia and Pacific Market Value (US$ Million) by Indication, 2024 to 2034 Figure 123: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 124: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034 Figure 125: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 126: South Asia and Pacific Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 129: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 130: South Asia and Pacific Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 133: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 134: South Asia and Pacific Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 137: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 138: South Asia and Pacific Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 141: South Asia and Pacific Market Attractiveness by Treatment, 2024 to 2034 Figure 142: South Asia and Pacific Market Attractiveness by Indication, 2024 to 2034 Figure 143: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034 Figure 145: East Asia Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 146: East Asia Market Value (US$ Million) by Indication, 2024 to 2034 Figure 147: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 148: East Asia Market Value (US$ Million) by Country, 2024 to 2034 Figure 149: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 150: East Asia Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 153: East Asia Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 154: East Asia Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 155: East Asia Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 157: East Asia Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 158: East Asia Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 159: East Asia Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 161: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 162: East Asia Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 163: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 164: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 165: East Asia Market Attractiveness by Treatment, 2024 to 2034 Figure 166: East Asia Market Attractiveness by Indication, 2024 to 2034 Figure 167: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034 Figure 169: Middle East and Africa Market Value (US$ Million) by Treatment, 2024 to 2034 Figure 170: Middle East and Africa Market Value (US$ Million) by Indication, 2024 to 2034 Figure 171: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034 Figure 172: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034 Figure 173: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034 Figure 174: Middle East and Africa Market Volume (Unit Pack) Analysis by Country, 2019 to 2034 Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034 Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034 Figure 177: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2019 to 2034 Figure 178: Middle East and Africa Market Volume (Unit Pack) Analysis by Treatment, 2019 to 2034 Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034 Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034 Figure 181: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2019 to 2034 Figure 182: Middle East and Africa Market Volume (Unit Pack) Analysis by Indication, 2019 to 2034 Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034 Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034 Figure 185: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034 Figure 186: Middle East and Africa Market Volume (Unit Pack) Analysis by Distribution Channel, 2019 to 2034 Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034 Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034 Figure 189: Middle East and Africa Market Attractiveness by Treatment, 2024 to 2034 Figure 190: Middle East and Africa Market Attractiveness by Indication, 2024 to 2034 Figure 191: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034 Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Recommendations
Explore Healthcare Insights
View Reports